retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 (LY3437943): of Action and Research Overview The Effects of Dual GLP-1/GIP
Description
Geiger et al., 2008
Liu Y, Tian Q, Yang J, Wang H, Hong T
How does Blue Cross manage and combat unnecessary costs of GLP-1 drugs
Both medications contain semaglutide, but they are FDA-approved for different uses
